Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mingdian Tan"'
Autor:
Surya Sukumaran, Mingdian Tan, Shulamit Fluss Ben-Uliel, Hui Zhang, Marta De Zotti, Mei-Sze Chua, Samuel K. So, Nir Qvit
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 3159-3172 (2023)
Heat shock protein 90 (Hsp90) and cell division cycle 37 (Cdc37) work together as a molecular chaperone complex to regulate the activity of a multitude of client protein kinases. These kinases belong to a wide array of intracellular signaling network
Externí odkaz:
https://doaj.org/article/678c69922afe4cac8daf23a7e2dbee8f
Autor:
Mingdian Tan PhD, Yizhi Ge MD, PhD, Xiaogang Wang Bsc, Yan Wang PhD, Yi Liu MD, PhD, Feng He PhD, Hongqi Teng PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
In recent years, extracellular vesicles (EVs) have gained significant attention due to their tremendous potential for clinical applications. EVs play a crucial role in various aspects, including tumorigenesis, drug resistance, immune escape, and reco
Externí odkaz:
https://doaj.org/article/fc7dd6243ced40a2860e4ca723edb68a
Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population‐based study
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 3, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/4dc2da45bac44fcd824135bf7a16d091
Publikováno v:
RSC Med Chem
Liver cancer, of which hepatocellular carcinoma (HCC) is the most common form, is one of the most lethal cancers worldwide. The five-year survival rate for HCC is below 9%, which can be attributed to late diagnosis and limited treatment options at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab991e7b88660bcaff2fba2206f28bbe
https://doi.org/10.1039/d1md00313e
https://doi.org/10.1039/d1md00313e
Autor:
Mingdian Tan, Xiaogang Wang, Renfang Xu, Qianqian Shi, Yunjie Cao, Li Cui, Pengfeng Gong, Kai Wang, Xiaozhou He
Publikováno v:
Translational Cancer Research
Background Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent cancers in renal cancer patients. Currently, mTOR and vascular endothelial growth factor (VEGF) inhibitors are the main targets of clinical drugs used to treat ccRCC. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7354be8989afea520c7e2070c51fba69
https://doi.org/10.21037/tcr-19-2246
https://doi.org/10.21037/tcr-19-2246
Autor:
Mingdian Tan
Publikováno v:
Cancer Therapy & Oncology International Journal. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fadb1961b8c63a6932639555d171373e
https://doi.org/10.19080/ctoij.2021.20.556037
https://doi.org/10.19080/ctoij.2021.20.556037
Autor:
Hui Zhang, Lakshmi Huttad, Wei Ye, Arutselvan Natarajan, Sanjiv S. Gambhir, Mei-Sze Chua, Samuel So, Mingdian Tan
Publikováno v:
Cancers, Vol 13, Iss 3977, p 3977 (2021)
Cancers
Volume 13
Issue 16
Cancers
Volume 13
Issue 16
Glypican-3 (GPC3) is an attractive diagnostic marker for hepatocellular carcinoma (HCC). We previously reported the potential of an 89Zr-labeled murine anti-GPC3 antibody (clone 1G12) for immunoPET imaging of HCC in orthotopic patient-derived xenogra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d72741fe5ef73ca180a84356e71d63c
https://www.mdpi.com/2072-6694/13/16/3977
https://www.mdpi.com/2072-6694/13/16/3977
Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population-based study
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 10, Iss 3, Pp n/a-n/a (2020)
Clinical and Translational Medicine, Vol 10, Iss 3, Pp n/a-n/a (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c191a67c557bad2345c8c4a35a8686b
https://pubmed.ncbi.nlm.nih.gov/32722868
https://pubmed.ncbi.nlm.nih.gov/32722868
Autor:
Hanzhi Luo, Qi Qiao, Shimin Zhao, Mingdian Tan, Li Wang, Zhifang Zheng, Danica Chen, Wei-Chieh Mu, Hou-Hsien Chiang, Ming He, Hao Wu, Rika Ohkubo
Publikováno v:
Cell Metab
It is well documented that the rate of aging can be slowed, but it remains unclear to which extent aging-associated conditions can be reversed. How the interface of immunity and metabolism impinges upon the diabetes pandemic is largely unknown. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0559762916b4e0f300857abd0316b63c
https://doi.org/10.1016/j.cmet.2020.01.009
https://doi.org/10.1016/j.cmet.2020.01.009